Phase I trial of 96 hour continuous infusion of dexrazoxane in patients with advanced malignancies.
Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Rashko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH. ()
Clinical Cancer Research - 2001 - ; 7: 1569-1576.

Visual compatibility of fluconazole with drugs given by continuous infusion.
Ishisaka DY. ()
Am J Hosp Pharm - 1994 - ; 51: 2290,2292.

Visual compatibility of hydroxyzine hydrochloride with various antineoplasic agents.
Marquardt ED. ()
Am J Hosp Pharm - 1988 - ; 45: 2127.